Verified today
A.J Sacks
Analyst, Aisling Capital
VC
Aisling Capital - investors & contacts
Everyone at Aisling Capital on Mintround. Browse free; unlock a verified email when you need it, or all 7 verified at once.
7 investors
Everyone at Aisling Capital
One payment, no subscription - every verified contact at Aisling Capital drops into your wallet.
Verified today
Stacey Seltzer
Partner, Aisling Capital
Decision maker
Verified today
Aftab Kherani
Partner, Aisling Capital
Decision maker
Verified today
Eric Aguiar
Partner, Aisling Capital
Decision maker
Verified today
Dennis Purcell
Unknown, Aisling Capital
Verified today
Dov Goldstein
Managing Partner, Aisling Capital
Decision maker
Verified today
Josh Bilenker
Partner, Aisling Capital
Decision maker
Recent investments at Aisling Capital
- Stratus TherapeuticsSeries B · $62M · 2023
- Forge BiologicsSeries C · $90M · 2022
- Dren BioSeries B · $65M · 2022
- CellevolveSeed · $6M · 2021
- Plant Culture SystemsPre Seed · $500K · 2021
- Monte Rosa TherapeuticsSeries B · $96M · 2020
- Eidos TherapeuticsSeries B · $64M · 2018
- Bristol-Myers SquibbPost Ipo Equity · $80M · 2017
- Zavante TherapeuticsSeries A · $45M · 2016
- SpiroxSeries C · $45M · 2016
- ViewRayPost Ipo Equity · $27M · 2015
- Aimmune TherapeuticsSeries B · $80M · 2015
What founders say
4.2Based on 2.2k reviews
Way faster than digging through LinkedIn for hours, and the contacts were accurate.
I paid for exactly the investors I needed. No subscription to forget to cancel.
Found a handful of relevant seed funds in my space within a few minutes.
The verified emails actually landed. Saved me a lot of guesswork.
No login, no fluff, no upsell. It just did what it said it would.
Leave a review
Let others know what you think.